Logo image of PMCB

PHARMACYTE BIOTECH INC (PMCB) Stock Analyst Earnings Estimates

NASDAQ:PMCB - Nasdaq - US71715X2036 - Common Stock - Currency: USD

0.892  +0.04 (+4.94%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Revenue
YoY % growth
PMCB revenue by date.PMCB revenue by date.
EBITDA
YoY % growth
PMCB ebitda by date.PMCB ebitda by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
PMCB ebit by date.PMCB ebit by date.
-18.98M-13.26M
30.14%
-6.07M
54.22%
-4.44M
26.85%
-6.98M
-57.21%
-4.1M
41.26%
-3.83M
6.59%
-3.63M
5.22%
-4.39M
-20.94%
-6.46M
-47.15%
-6.52M
-0.93%
Operating Margin
PMCB operating margin by date.PMCB operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
PMCB eps by date.PMCB eps by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2023
Q2Q % growth
-0.07
-45.10%
-0.070.00-3.64%
Q4 2022
Q2Q % growth
-0.07
1.96%
-0.04-0.03-71.57%
Q3 2022
Q2Q % growth
-0.04 -0.050.0121.57%
Q2 2022
Q2Q % growth
-0.06 -0.070.0115.97%
PMCB Yearly EPS VS EstimatesPMCB Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2022 -10 -20 -30
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A